[HTML] nejm.org

[HTML][HTML] Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma

SJ Schuster, MR Bishop, CS Tam… - … England Journal of …, 2019 - Mass Medical Soc
Background Patients with diffuse large B-cell lymphoma that is refractory to primary and
second-line therapies or that has relapsed after stem-cell transplantation have a poor …
被引用次数：3524 相关文章

Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma

SJ Schuster, MR Bishop, CS Tam, EK Waller… - N. Engl. J …, 2019 - kups.ub.uni-koeln.de
BACKGROUND Patients with diffuse large B-cell lymphoma that is refractory to primary and
second-line therapies or that has relapsed after stern-cell transplantation have a poor …

Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma

SJ Schuster, MR Bishop, CS Tam… - New England …, 2019 - ohiostate.elsevierpure.com
Background: Patients with diffuse large B-cell lymphoma that is refractory to primary and
secondline therapies or that has relapsed after stem-cell transplantation have a poor …

Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma

SJ Schuster, MR Bishop, CS Tam… - New England …, 2019 - mdanderson.elsevierpure.com
Background: Patients with diffuse large B-cell lymphoma that is refractory to primary and
secondline therapies or that has relapsed after stem-cell transplantation have a poor …

Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma

SJ Schuster, MR Bishop, CS Tam… - … England Journal of …, 2019 - ohsu.elsevierpure.com
Background: Patients with diffuse large B-cell lymphoma that is refractory to primary and
secondline therapies or that has relapsed after stem-cell transplantation have a poor …

Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma

SJ Schuster, MR Bishop, CS Tam… - The New England …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Patients with diffuse large B-cell lymphoma that is refractory to primary and
second-line therapies or that has relapsed after stem-cell transplantation have a poor …

Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma

JULIET Investigators - New England …, 2019 - researchinformation.amsterdamumc …
Background: Patients with diffuse large B-cell lymphoma that is refractory to primary and
secondline therapies or that has relapsed after stem-cell transplantation have a poor …

Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma

SJ Schuster, MR Bishop, CS Tam… - The New England …, 2019 - research.monash.edu
Background: Patients with diffuse large B-cell lymphoma that is refractory to primary and
secondline therapies or that has relapsed after stem-cell transplantation have a poor …

Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma

JULIET Investigators - New England Journal of Medicine, 2019 - experts.umn.edu
BACKGROUND: Patients with diffuse large B-cell lymphoma that is refractory to primary and
second-line therapies or that has relapsed after stem-cell transplantation have a poor …

Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma.

SJ Schuster, MR Bishop, CS Tam… - The New England …, 2018 - europepmc.org
Background Patients with diffuse large B-cell lymphoma that is refractory to primary and
second-line therapies or that has relapsed after stem-cell transplantation have a poor …